Skip to main content
Fig. 5 | Critical Care

Fig. 5

From: An area under the concentration–time curve threshold as a predictor of efficacy and nephrotoxicity for individualizing polymyxin B dosing in patients with carbapenem-resistant gram-negative bacteria

Fig. 5

Kaplan–Meier estimates of the incidence of AKI to day 30 after administration of polymyxin B. Stratified by AUCss,24 h (a) and C0h (b). AKI, acute kidney injury; AUCss,24 h, the area under the plasma concentration–time curve across 24 h at steady state; and C0h, trough concentration

Back to article page

Critical Care

ISSN: 1364-8535